Divya Madhavarapu, MD
Endocrinology, Diabetes & Metabolism · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Madhavarapu’s office at (650) 934-7808 to ask if they take your plan before you enroll.
Drugs they prescribed that Part D paid
$54,013
Pharmacies billed $54,013 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 359) in 2024. At or below the middle of the specialty; the typical student in an organized health care education/training program clinician is at 0%.
263 generic and 81 brand-name prescriptions · $54,013 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 17 | $18,247 | $1,073 |
| Lantus Solostar | 12 | $1,735 | $145 |
| Labetalol | 11 | $674 | $61 |
| Atorvastatin | 29 | $458 | $16 |
| Hydralazine | 11 | $425 | $39 |
See all 11 drugs
| Eliquis | 17 | $18,247 | $1,073 |
| Lantus Solostar | 12 | $1,735 | $145 |
| Labetalol | 11 | $674 | $61 |
| Atorvastatin | 29 | $458 | $16 |
| Hydralazine | 11 | $425 | $39 |
| Amlodipine Besylate | 27 | $327 | $12 |
| Omeprazole | 12 | $313 | $26 |
| Ezetimibe | 12 | $301 | $25 |
| Levothyroxine | 19 | $197 | $10 |
| Losartan | 17 | $161 | $9 |
| Metformin | 13 | $84 | $6 |
Year by year
| 2024 | 359 | 57 | 0% (0) | 23% | $54,013 |
| 2023 | 434 | 65 | 0% (0) | 16% | $74,278 |
| 2022 | 315 | 59 | 0% (0) | None | $34,243 |
| 2021 | 103 | 34 | 0% (0) | None | $7,075 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 8 drugs
| Atorvastatin | 39 | $735 | $19 |
| Amlodipine Besylate | 43 | $642 | $15 |
| Rosuvastatin | 14 | $413 | $30 |
| Losartan | 16 | $401 | $25 |
| Levothyroxine | 20 | $305 | $15 |
| Albuterol Sulfate Hfa | 11 | $234 | $21 |
| Lisinopril | 21 | $162 | $8 |
| Metformin | 15 | $83 | $6 |
2022: 6 drugs
| Atorvastatin | 26 | $332 | $13 |
| Omeprazole | 11 | $293 | $27 |
| Gabapentin | 22 | $290 | $13 |
| Levothyroxine | 14 | $206 | $15 |
| Lisinopril | 17 | $136 | $8 |
| Amlodipine Besylate | 16 | $55 | $3 |
2021: 1 drug
| Atorvastatin | 11 | $86 | $8 |
Money from drug and device companies
$168 in 2025
| 2025 | 2 | 2 | None | $168 |
| 2024 | 1 | 1 | None | $24 |
| 2023 | 1 | 1 | None | $125 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
See all 2 published payments
| Medtronic | Meals · 2025-11-20 | Minimed 780g | $32 |
| Amgen | Meals · 2025-03-05 | Evenity | $136 |
See earlier years (2024, 2023)
2024: $24
| Mannkind | Afrezza | $24 | 1 payment
|
2023: $125
| Gilead Sciences | Epclusa | $125 | 1 payment
|
Professional record
- NPI
- 1659958684
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RE0101X (207RE0101X)
- Mailing address
- Po Box 276950, Sacramento, CA, 95827
- NPI first listed
- 2021-03-25
- NPI last updated
- 2026-09-14
- NPI record certified
- 2026-09-14
This is when the NPI record was last certified, not a medical board exam.